Clinical Trial

Study of the Performance of the GLUCUBE System in Patients With Type 2 Diabetes

Completed
View on ClinicalTrials.gov →
Summary
This study is a prospective, single center, open label clinical investigation. The primary objective of the study is to evaluate the performance of GLUCUBE in patients with diabetes type 2 and how the accuracy of the system improves as the time of use by the patient increases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-10.
Status change: Recruiting → Completed 2026-01-09
Trial Details
NCT Number NCT07075796
Lead Sponsor iGluco
Conditions Diabetes Mellitus, Type 2
Enrollment 52 participants
Start Date 2025-06-02
Primary Completion 2025-11-28 (estimated)
Study Completion 2025-11-28 (estimated)
Updated on ClinicalTrials.gov 2026-01-13